Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.57EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.57ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.57ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.57EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.57EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EF.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EF.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.313EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.313ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.313EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.313EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.313ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.313ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used